France to Reimburse Patients for Anti-Obesity Drugs

The move, which will be effective from the middle of next month, makes Paris the first government in the EU to subsidize such medications.

Wegovy at a pharmacy in London on March 8, 2024. Hollie Adams/Reuters

France is set to begin reimbursing severely obese people for the cost of weight-loss drugs, French Health Minister Stéphanie Rist said on May 28.

She said that Paris would subsidize the use of Danish company Novo Nordisk’s Wegovy and American pharma giant Eli Lilly’s Mounjaro from mid-June.